Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets
- PMID: 18071026
- DOI: 10.2337/db07-0847
Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets
Erratum in
- Diabetes. 2014 Nov;63(11):3974
Retraction in
-
Statement of Retraction. Transcription Factor 7-Like 2 Regulates β-Cell Survival and Function in Human Pancreatic Islets.Diabetes. 2017 Jun;66(6):1729-1730. doi: 10.2337/db17-rt06a. Epub 2017 Mar 29. Diabetes. 2017. PMID: 28356310 Free PMC article. No abstract available.
Expression of concern in
-
Expression of Concern. Transcription Factor 7-Like 2 Regulates β-Cell Survival and Function in Human Pancreatic Islets. Diabetes 2008;57:645-653. DOI: 10.2337/db07-0847; and erratum. Diabetes 2014;63:3974. DOI: 10.2337/db14-er11.Diabetes. 2016 Aug;65(8):2461. doi: 10.2337/db16-ec08. Diabetes. 2016. PMID: 27456622 No abstract available.
Abstract
Objective: Type 2 diabetes is characterized by impaired insulin secretion in response to increased metabolic demand. This defect in beta-cell compensation seems to result from the interplay between environmental factors and genetic predisposition. Genome-wide association studies reveal that common variants in transcription factor 7-like 2 (TCF7L2) are associated with increased risk of type 2 diabetes. The aim of the present study was to establish whether TCF7L2 plays a role in beta-cell function and/or survival.
Research design and methods: To investigate the effects of TCFL7L2 depletion, isolated islets were exposed to TCF7L2 small interfering RNA (siRNA) versus scrambled siRNA, and beta-cell survival and function were examined. For TCF7L2 overexpression, islets were cultured in glucose concentrations of 5.5-33.3 mmol/l and the cytokine mix interleukin-1 beta/gamma-interferon with or without overexpression of TCF7L2. Subsequently, glucose-stimulated insulin secretion (GSIS), beta-cell apoptosis [by transferase-mediated dUTP nick-end labeling assay and Western blotting for poly(ADP-ribose) polymerase and Caspase-3 cleavage], and beta-cell proliferation (by Ki67 immunostaining) were analyzed.
Results: Depleting TCF7L2 by siRNA resulted in a 5.1-fold increase in beta-cell apoptosis, 2.2-fold decrease in beta-cell proliferation (P < 0.001), and 2.6-fold decrease in GSIS (P < 0.01) in human islets. Similarly, loss of TCF7L2 resulted in impaired beta-cell function in mouse islets. In contrast, overexpression of TCF7L2 protected islets from glucose and cytokine-induced apoptosis and impaired function.
Conclusions: TCF7L2 is required for maintaining GSIS and beta-cell survival. Changes in the level of active TCF7L2 in beta-cells from carriers of at-risk allele may be the reason for defective insulin secretion and progression of type 2 diabetes.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
